Regal Partners Ltd Has $4.99 Million Stake in Core Scientific, Inc. $CORZ

Key Points

• Regal Partners Ltd cut its stake in Core Scientific by 55.5% in Q3, leaving it with 278,070 shares worth about $4.99 million (roughly 0.09% of the company).
• Core Scientific secured a $1.0 billion loan from Morgan Stanley to fund its AI pivot and growth initiatives, and several brokerages have upgraded the stock, leaving a consensus rating of "Moderate Buy" with an average target near $24.84.
• Results remain mixed: Q4 EPS of $0.42 beat estimates, but revenue of $79.8M missed forecasts and fell 16% year‑over‑year, keeping execution and top‑line recovery as key near‑term risks.

Regal Partners Ltd lowered its stake in shares of Core Scientific, Inc. (NASDAQ:CORZ - Free Report) by 55.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 278,070 shares of the company's stock after selling 347,143 shares during the period. Regal Partners Ltd owned approximately 0.09% of Core Scientific worth $4,989,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. HHM Wealth Advisors LLC raised its position in shares of Core Scientific by 96.5% in the 2nd quarter. HHM Wealth Advisors LLC now owns 1,926 shares of the company's stock valued at $33,000 after acquiring an additional 946 shares during the period. Osaic Holdings Inc. grew its holdings in Core Scientific by 112.1% during the second quarter. Osaic Holdings Inc. now owns 2,017 shares of the company's stock valued at $34,000 after purchasing an additional 1,066 shares during the period. Advisors Asset Management Inc. increased its stake in Core Scientific by 68.3% in the second quarter. Advisors Asset Management Inc. now owns 2,690 shares of the company's stock valued at $46,000 after purchasing an additional 1,092 shares in the last quarter. PNC Financial Services Group Inc. increased its stake in Core Scientific by 396.8% in the second quarter. PNC Financial Services Group Inc. now owns 3,731 shares of the company's stock valued at $64,000 after purchasing an additional 2,980 shares in the last quarter. Finally, Russell Investments Group Ltd. raised its holdings in Core Scientific by 61.9% in the second quarter. Russell Investments Group Ltd. now owns 3,942 shares of the company's stock worth $67,000 after purchasing an additional 1,507 shares during the period.

More Core Scientific News

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Core Scientific secured a $1.0 billion loan from Morgan Stanley to fund its AI pivot and provide liquidity for growth initiatives — this materially reduces near‑term financing risk and supports capital spending for compute/AI activities, which is constructive for valuation if execution follows. Core Scientific secures $1 billion loan
• Positive Sentiment: HC Wainwright reiterated a "Buy" rating, lifted FY‑2026 estimates (now $0.33 EPS from $0.16 previously) and published quarterly EPS forecasts with a $25 price target — analyst upgrade increases upside narrative and can buoy investor sentiment. HC Wainwright Reiterates Buy
• Positive Sentiment: Needham & Company upgraded Core Scientific — another independent analyst endorsement that may attract buyers or support a rerating if momentum continues. Needham upgrades CORZ
• Neutral Sentiment: Short‑interest reports show 0 shares and produce NaN changes and a 0.0 days‑to‑cover figure — this appears to be a data anomaly and is not reliable as a signal of bearish positioning. (No actionable short‑squeeze implications absent corrected data.)
• Negative Sentiment: Ladenburg Thalmann/SH lowered expectations for CORZ, which could weigh on sentiment and increase selling pressure among investors focused on near‑term fundamentals. Ladenburg lowers expectations
• Negative Sentiment: Recent results were mixed: Core beat Q4 EPS but missed revenue estimates and saw year‑over‑year revenue decline — ongoing top‑line pressure means the market remains sensitive to execution risk on the AI pivot and margin recovery, which can cap near‑term upside.

Analyst Ratings Changes

A number of brokerages have recently weighed in on CORZ. Citigroup raised shares of Core Scientific from a "market perform" rating to an "outperform" rating in a research report on Thursday, December 18th. Citizens Jmp upgraded shares of Core Scientific from a "market perform" rating to an "outperform" rating and set a $30.00 price objective for the company in a research report on Thursday, December 18th. Keefe, Bruyette & Woods raised their price objective on Core Scientific from $19.00 to $25.00 and gave the stock a "moderate buy" rating in a research note on Tuesday, January 27th. Needham & Company LLC upgraded Core Scientific from a "hold" rating to a "buy" rating and set a $23.00 target price on the stock in a report on Tuesday, March 3rd. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of Core Scientific in a research note on Wednesday, January 21st. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, three have issued a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $24.84.

Core Scientific Stock Performance

Shares of CORZ opened at $14.86 on Friday. The firm has a market cap of $4.69 billion, a P/E ratio of 12.70 and a beta of 6.87. Core Scientific, Inc. has a twelve month low of $6.20 and a twelve month high of $23.63. The firm's 50 day moving average price is $17.27 and its two-hundred day moving average price is $16.97.

Core Scientific (NASDAQ:CORZ - Get Free Report) last issued its quarterly earnings data on Monday, March 2nd. The company reported $0.42 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.69. The company had revenue of $79.76 million for the quarter, compared to the consensus estimate of $118.45 million. During the same period in the prior year, the company earned ($0.69) EPS. The firm's revenue was down 16.0% on a year-over-year basis. On average, sell-side analysts anticipate that Core Scientific, Inc. will post 0.52 earnings per share for the current fiscal year.

Core Scientific Profile

Core Scientific, Inc NASDAQ: CORZ is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific's service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.

Want to see what other hedge funds are holding CORZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Scientific, Inc. (NASDAQ:CORZ - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.